Annual report pursuant to Section 13 and 15(d)

Stock Options (Details)

v2.4.0.8
Stock Options (Details) (USD $)
 12 Months Ended 0 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Stock options
Dec. 31, 2012
Stock options
Dec. 31, 2011
Stock options
Dec. 31, 2013
Stock options
Minimum
Dec. 31, 2013
Stock options
Maximum
Dec. 31, 2013
Employee options
Every six months
Dec. 31, 2013
Directors and officer options
Dec. 31, 2013
Directors and officer options
Quarterly
Dec. 31, 2013
Consultants options
Minimum
Dec. 31, 2013
Consultants options
Maximum
Sep. 27, 2011
AxoGen Plan
Dec. 31, 2013
AxoGen Plan
Dec. 31, 2013
AxoGen Corporation (AC)
AC Plan
Stock Option disclosures                              
Number of shares of common stock authorized for issuance                         2,300,000    
Shares authorized for issuance                           2,750,000 18,144,658
Vesting percentage               12.50%   25.00%          
Vesting period               4 years 0 years 1 year 3 years 10 years      
Option term           7 years 10 years                
Share-based compensation expense $ 671,887 $ 495,077                          
Stock option activity                              
Options, Outstanding at the beginning of the period (in shares)     1,799,991 1,945,688                      
Options, Granted (in shares)     261,000 267,576                      
Options, Forfeited (in shares)     (58,843) (354,932)                      
Options, Exercised (in shares)     (32,656) (58,341)                      
Options, Outstanding at the end of the period (in shares)     1,969,492 1,799,991 1,945,688                    
Options, Exercisable (in shares)     1,294,290                        
Weighted Average Exercise Price, Outstanding at the beginning of the period (in dollars per share)     $ 2.54 $ 2.41                      
Weighted Average Exercise Price, Granted (in dollars per share)     $ 3.72 $ 2.99                      
Weighted Average Exercise Price, Forfeited (in dollars per share)     $ (3.48) $ (2.48)                      
Weighted Average Exercise Price, Exercised (in dollars per share)     $ (2.25) $ (0.27)                      
Weighted Average Exercise Price, Outstanding at the end of the period (in dollars per share)     $ 2.68 $ 2.54 $ 2.41                    
Weighted Average Exercise Price, Exercisable (in dollars per share)     $ 2.57                        
Weighted Average Remaining Contractual Term, Outstanding     6 years 7 months 10 days 7 years 7 months 28 days 7 years 4 months 6 days                    
Weighted Average Remaining Contractual Term, Exercisable     6 years 4 months 13 days                        
Additional option disclosures                              
Average fair value of options granted     $ 3.72 $ 2.99                      
Intrinsic value of options exercised     48,000 173,000                      
Intrinsic value of options outstanding     3,571,000 288,000                      
Intrinsic value of options exercisable     2,487,000 0                      
Total future stock compensation expense related to nonvested awards $ 1,233,000                            
Weighted average period of recognition of future stock compensation expense 2 years 22 days